EUVIMEDExplore EUVIMED
Randomisierte kontrollierte StudieOpen access

Economic Evaluation of a Multicomponent mHealth Intervention for Stroke Management in Rural China: Cluster-Randomized Trial With 6-Year Follow-Up

Bolu Yang iD, Enying Gong iD, Xingxing Chen iD, Jie Tan iD, Nicholas Peoples iD, Yuhan Li iD, Jiayu Cai iD, Yan Li iD, Brian Oldenburg iD, Chen Chen iD, Dejin Dong iD, Xiaochen Zhang iD and 3 more

JMIR mHealth and uHealth · 2025

DOI: 10.2196/75326 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR mHealth and uHealth, 2025. Written by Bolu Yang and 14 co-authors. Institution: School of Public Health, Wuhan University, Wuhan, China. Major MEDLINE topics: Stroke, Telemedicine. Cited 6 times so far (Crossref); 46 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Background

To bridge the gap between clinical guidelines and suboptimal stroke management in rural settings, we conducted an implementation trial using evidence-based, mobile health–enabled strategies to empower primary care providers in rural China. The system-integrated and digital technology–enabled model of care (SINEMA) model was shown to significantly reduce blood pressure and mortality among people with stroke in rural China.

Objective

This study aimed to evaluate the cost-effectiveness of the SINEMA intervention within both the active trial and the post-trial observational periods and its budget impact for potential nationwide scalability.

Methods

In the cluster-randomized implementation trial (the SINEMA trial), 50 villages were randomized to either a 1-year intervention (2017-2018) or usual care, with 1299 patients with stroke followed up until 2022-2023—6 years after the trial baseline. The incremental cost-effectiveness ratios (ICER) for systolic blood pressure reduction and quality-adjusted life year gains were estimated from a health sector perspective. Both probabilistic and deterministic sensitivity analyses were conducted to assess the robustness of the findings. Additionally, a budget impact analysis was performed from a public payer perspective to estimate the per-capita and total costs of national scale-up under 2 scenarios: a standalone intervention and integration into the existing basic public health service system.

Results

The ICER per 1 mmHg systolic blood pressure reduction was $8.4 for the within-trial estimation. The ICER per quality-adjusted life year gained was $837.9 within-trial and $727.9 post-trial, both highly cost-effective relative to any commonly adopted thresholds and robust in sensitivity analyses. The first-year budget impact ranged from $115.6 million to $197.7 million in the 2 scenarios, reducing to $46.6 million to $78.7 million by year 5, with a per-capita cost of $0.03-$0.06.

Conclusions

Our findings demonstrate that the SINEMA intervention was cost-effective during the trial period and remained so throughout the 6-year sustainability observation period. These results highlight the potential of adopting similar health system–integrated, mobile health–enabled strategies to enhance the management of stroke and other chronic diseases in resource-limited settings. Trial Registration ClinicalTrials.gov NCT0318585, ClinicalTrials.gov NCT05792618; https://clinicaltrials.gov/study/NCT03185858 and https://clinicaltrials.gov/study/NCT05792618 International Registered Report Identifier (IRRID) RR2-10.3389/fneur.2023.1145562

Subjects

MeSH terms (MEDLINE)

StrokeTelemedicineHumansChinaCost-Benefit AnalysisFemaleMaleMiddle AgedFollow-Up StudiesRural PopulationAgedQuality-Adjusted Life YearsAdult

Author keywords

budget impact analysiscluster-randomized trialeconomic evaluationmHealthstroke secondary prevention

Authors and institutions

  • School of Public Health, Wuhan University, Wuhan, China.
  • Global Health Research Center, Duke Kunshan University, Kunshan, China.
  • School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Harvard-affiliated Emergency Medicine Residency, Mass General Brigham, Boston, MA, United States.
  • School of Public Health, Shanghai Jiao Tong University, Shanghai, China.

ORCID profiles: Bolu Yang, Enying Gong, Xingxing Chen, Jie Tan, Nicholas Peoples, Yuhan Li, Jiayu Cai, Yan Li, Brian Oldenburg, Chen Chen, Dejin Dong, Xiaochen Zhang, Eric Finkelstein, Lei Si, Lijing L Yan

Funding

  • Wellcome Trust

Cite

APA

Yang, B., Gong, E., Chen, X., Tan, J., Peoples, N., Li, Y., Cai, J., Li, Y., Oldenburg, B., Chen, C., Dong, D., Zhang, X., Finkelstein, E., Si, L., & Yan, L. L. (2025). Economic Evaluation of a Multicomponent mHealth Intervention for Stroke Management in Rural China: Cluster-Randomized Trial With 6-Year Follow-Up. JMIR mHealth and uHealth. https://doi.org/10.2196/75326

Vancouver

Yang B, Gong E, Chen X, Tan J, Peoples N, Li Y, et al. Economic Evaluation of a Multicomponent mHealth Intervention for Stroke Management in Rural China: Cluster-Randomized Trial With 6-Year Follow-Up. JMIR mHealth and uHealth. 2025. doi:10.2196/75326

BibTeX
@article{Yang2025,
  author = {Yang, Bolu and Gong, Enying and Chen, Xingxing and Tan, Jie and Peoples, Nicholas and Li, Yuhan and Cai, Jiayu and Li, Yan and Oldenburg, Brian and Chen, Chen and Dong, Dejin and Zhang, Xiaochen and Finkelstein, Eric and Si, Lei and Yan, Lijing L},
  title = {Economic Evaluation of a Multicomponent mHealth Intervention for Stroke Management in Rural China: Cluster-Randomized Trial With 6-Year Follow-Up},
  journal = {JMIR mHealth and uHealth},
  year = {2025},
  doi = {10.2196/75326}
}
Start for free →